Our Development Capabilities
Medefil has established a state of the art R&D facility to develop injectable products. The laboratory scientific staff possesses a good blend of experience and expertise for developing injectable drugs which can be scaled up to Medefil’s existing manufacturing facility.
- Chromatographic systems (HPLCs, UPLCs, IC, CAD, GPC, and GCs) and Mass Spectroscopy
- Dissolution capability including USP APP-2 and USP APP-4
- Various wet chemistry and identification techniques: Titrations, KF, ROI, LOD, UV, FTIR, Polarimeter
- Extraction equipment’s including reflux vessels, rotary evaporator.
- Mass Spectroscopy for elemental extractable and leachable impurities by ICPMS
- Mass Spectroscopy for volatile and semi-volatile extractable and leachable impurities by GC-MS
- Mass Spectroscopy for non-volatile extractable and leachable impurities by LC-MS/MS-TOF